Daniel Przybysz M.D. (@przybyszmd) header
Daniel Przybysz M.D. (@przybyszmd) profile picture

Clinical Director and Head of Radiation Oncology RadioSerra Radiation Oncology

Rio de Janeiro, Brazil
Joined October 2018
Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)Photo by Daniel Przybysz M.D. (@przybyszmd)
Daniel Przybysz M.D. retweeted
Primary care physicians hold all the cards when it comes to getting the word out about lung screening. 🫁
🫁 ALCSI is incredibly excited to be hosting a trailblazing educational session at AAFP FMX @aafp tomorrow! Family physicians and primary care physicians: YOU have the power to improve lung cancer survivorship for your patients! Pope Leo XIV’s lung cancer, caught at an early stage, is a good reminder of why early detection matters. Family physicians play an important role in identifying patients eligible for lung cancer screening, facilitating early detection, and ultimately saving lives. Join us tomorrow at AAFP FMX for “Clearing the Air About Lung Cancer Screening: A Guide for Primary Care.” Our panel of family physicians, thoracic surgeons, and leaders from the American Lung Cancer Screening Initiative, American Cancer Society, and National Lung Cancer Roundtable will cover: • The critical role of family physicians and primary care physicians in increasing lung cancer screening and improving survivorship • Practical tools and resources to identify eligible patients and integrate lung cancer screening into your practice • Real-world experiences and lessons learned from primary care physicians who have successfully built lung cancer screening programs • Common misconceptions and barriers to screening, and strategies to overcome them 📅 Wednesday, October 21, 9:30–10:30 AM 📍 Room 107AB, Music City Center 🥐 BREAKFAST INCLUDED! Thank you to our sponsors @AstraZeneca, @Eli Lilly, @Medtronic, and @Amgen for making this event possible! Speakers and Panelists: Dr. Heather Bittner-Fagan, Dr. Vickie Fowler (@VickieAFowler), Dr. Michael Gieske (@mrgieske), Dr. Ella Kazerooni (@ellakaz), Lauren Rosenthal, Priyanka Senthil (@PriyankaSenth16), Dr. Robert Smith, Dr. Chi-Fu Jeffrey Yang (@ChiFuJeffYang) @AmericanCancer @NLCRTnews #FMX2026 #LungCancerScreening #FamilyMedicine #PrimaryCare #ALCSI #AAFPFMX
2
5
835
☢️ A More Stringent Hematologic Toxicity Control for Hypofractionated Cervical Cancer Concurrent Chemoradiation via CT- and MRI-based Bone Marrow Dosimetry: Pooled Analysis from HYPOCx-iRex and Single-Institute EMBRACE-II Studies 🔗 advancesradonc.org/article/S… 👉🏻This study pooled data from EMBRACE-II (without BM-sparing) and HYPOCx-iRex (with BM-sparing) to: (1) identify dosimetric constraints for HemTox mitigation, particularly for the HYPO 44 Gy/20F regimen; and (2) compare CT- versus MRI-based BM dose correlations with HemTox as practical surrogates for active marrow sparing. @Advances_ASTRO #RadOnc @UTMDAnderson
7
16
1,062
Daniel Przybysz M.D. retweeted
🚨 ESMO 2026: 15 Trials That Could Change Oncology Practice! From personalized cancer vaccines and bispecific antibodies to next-generation ADCs, major results are coming. 🔥 My Top 15 to Watch: 1. INTerpath-001 | Melanoma 2. SAFFRON | EGFR+ NSCLC 3. Krascendo 1 | KRAS G12C NSCLC 4. DeLLphi-305 | ES-SCLC 5. HARMONi-GI1 | Biliary 6. VOLGA | Bladder 7. DASL-HiCaP | Prostate 8. NATALEE | Breast 9. TRIO-US B-12 TALENT | Breast 10. ENERGIZE | Bladder 11. CLARITY-Gastric 01 | Gastric 12. KEYNOTE-C93 | Endometrial 13. KEYNOTE-B49 | Breast 14. LITESPARK-011 | RCC 15. SigVie-002 | NSCLC 📊 The big question: Which trials will deliver meaningful survival benefits and redefine standards of care? Not every positive trial is practice-changing. 👨‍⚕️ Oncologists, which trial are you watching most closely? #ESMO26 #Oncology #CancerResearch @ASCO @oncoalert @myesmo @esmo_open
8
98
6
294
53,299
Great to be part of the #ASTRO2026 highlights! 🚀☢️ Amazing science, innovation, and even better people pushing radiation oncology forward. Always a privilege to reconnect, exchange ideas, and come back energized for what’s next. 🌎🧠⚡ Thanks @OncoDaily for the feature! 🙌
1
10
384
Another #ASTRO26 for the books! 📚 Team #RadioSerra ☢️ killing it in #Boston 🦞 🇺🇸
1
4
407
Another great encounter at #ASTRO2026! @AndrearicFili superstar 🇮🇹 #RadOnc, friend and ART Committee member! ☢️ Thanks for all the laughing! 🤣
🤖 Made with AI
2
1
200
Daniel Przybysz M.D. retweeted
Clinical trials session packed for some amazing trial data including long term clinical and functional outcomes for LDRT for knee osteoarthritis. Great work coordinating the publication of this data @KoneruMd ! #ASTRO2026
8
36
1,622
Proud to see superstar friend @KevinMoorePhD and @SiemensHealth new ☢️ tool to fight cancer with precision and technology. Accela surges to deliver safer and more dynamic RT at @ASTRO_org #ASTRO2026
1
194
Day 2 at #ASTRO2026. New tech ☢️ towards striking out #Cancer 🥊! 🦞 🇺🇸
1
89
Daniel Przybysz M.D. retweeted
Breakthrough findings at the #ASTRO26 clinical trials session presented by Dr. Leslie Ballas of Cedars Sinai. Palliative RT for MM given as 4 Gy in 1-2 fractions shows meaningful pain relief while minimizing hematological AEs.
2
19
30
2,744
Thanks for the opportunity again 🇺🇸 to be on your side Léo, Clarisse and all of the @Accuray team. Good seeing you and all new tech ☢️ in #Boston 🦞 at #ASTRO2026.
4
250
✈️ Wheels up to Boston 🦞 🇺🇸 for #ASTRO26! ☢️ Our team's 15+ year tradition 🏆: learning 📚, interdisciplinary talks 🧠, old friends 🤝 and lots of fun 😄. Follow along! 👀 #RadiationOncology #RadioSerra #HospitalSirioLibanes
3
172
Daniel Przybysz M.D. retweeted
For those coming to #ASTRO26 on Sunday, keep an eye on the weather! Try to sneak in before the winds. @ASTRO_org Powerful nor’easter could bring a rough weekend to the Northeast wapo.st/4djKMl9
1
1
7
2,250
Back #home 🇧🇷, across the #PACIFIC and things keep rolling 🫁! Let’s go!!! #RadOnc #RadioSerra
1
168
Daniel Przybysz M.D. retweeted
That’s a Wrap for WCLC26! - Daniel Przybysz @przybyszmd oncodaily.com/voices/daniel-…
1
2
307
Time to go home! 감사합니다 🇰🇷! Off to @ASTRO_org in #Boston next week! 🇺🇸 ✈️ Excited w/ new horizons and AI 🤖 tech yet to come. Maybe someday this (pic) will be a #MDT meeting?! #WCLC26 #ASTRO26
1
5
359
This year, we brought new voices to Lung Cancer Cancer Considered, including our patient advocates and oncology nurses (APPs) Their perspectives reminded us that advancing lung cancer care requires every voice at the table. The official @IASLC podcast #WCLC26
2
12
34
1,460
That’s a wrap for #WCLC26 🇰🇷! What an amazing time. 🫁 Our patients always deserve the #best care. ☢️ Thanks to the @IASLC for the invitation and partnership. And to @psy_oppa . Let’s keep it #GangnamStyle! 🕺 We’ll see y’all in #Denver27 🐴 🏔️ 🇺🇸!!! #RadOnc #RadioSerra
1
10
392